
Publications
Scientific articles and outputs from PGNM teams and collaborators.
About
PGNM publications reflect the scientific output of the laboratory’s teams and collaborators, spanning fundamental mechanisms, disease models, technologies and translational research.
2006
NOV/CCN3 impairs muscle cell commitment and differentiation.,
Exp Cell Res 2006 Jun; 312(10): 1876-89.
2006
Dynamic interaction of TTDA with TFIIH is stabilized by nucleotide excision repair in living cells.,
PLoS Biol 2006 Jun; 4(6): e156.
2006
The C. elegans HP1 homologue HPL-2 and the LIN-13 zinc finger protein form a complex implicated in vulval development,
Developmental Biology.
2006
ICP0 of herpes simplex virus type 1 : ubiquitination at the service of infection (review in French).,
Virologie.
2005
The protein ICP0 of herpes simplex virus type 1 is targeted to nucleoli of infected cells. Brief report.,
Archiv für die gesamte Virusforschung.
2005
Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction.,
Am J Physiol Cell Physiol 2005 Oct; 289(4): C908-17.
2005
Nitric oxide synthase inhibition affects sarcoplasmic reticulum Ca2+ release in skeletal muscle fibres from mouse.,
J Physiol 2005 Sep; 567(Pt 3): 815-28.
2005
Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein.,
J Gene Med 2005 Sep; 7(9): 1187-99.
2005
Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression.,
Nat Neurosci 2005 Mar; 8(3): 313-21.
2005
The yeast multidrug transporter Qdr3 (Ybr043c): localization and role as a determinant of resistance to quinidine, barban, cisplatin, and bleomycin.,
Biochem Biophys Res Commun 2005 Feb; 327(3): 952-9.
2005
Characterisation of the antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICP0 protein.,
The Journal of Gene Medicine.
2005
The protein ICP0 of herpes simplex virus type 1 is targeted to nucleoli of infected cells.,
Archives of Virology.
2005
[Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene].,
J Soc Biol 2005 ; 199(1): 61-77.
2004
14-3-3 gamma associates with muscle specific kinase and regulates synaptic gene transcription at vertebrate neuromuscular synapse.,
Proc Natl Acad Sci U S A 2004 Dec; 101(52): 18189-94.
2004
MUSK, a new target for mutations causing congenital myasthenic syndrome.,
Hum Mol Genet 2004 Dec; 13(24): 3229-40.
2004
Control of intracellular calcium in the presence of nitric oxide donors in isolated skeletal muscle fibres from mouse.,
J Physiol 2004 Nov; 560(Pt 3): 779-94.
2004
Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1.,
J Virol 2004 Jul; 78(13): 6744-57.
2004
Thrombin reduces MuSK and acetylcholine receptor expression along with neuromuscular contact size in vitro.,
Eur J Neurosci 2004 Apr; 19(8): 2099-108.
2004
Conditional gene knock-down by CRE-dependent short interfering RNAs.,
EMBO Rep 2004 Feb; 5(2): 178-82.
2004
Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation.,
Mol Cell Biol 2004 Feb; 24(3): 1245-55.